Fresenius Medical Care Stock Market Value
| FMS Stock | USD 22.02 0.31 1.39% |
| Symbol | Fresenius |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fresenius Medical. If investors know Fresenius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fresenius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Fresenius Medical Care is measured differently than its book value, which is the value of Fresenius that is recorded on the company's balance sheet. Investors also form their own opinion of Fresenius Medical's value that differs from its market value or its book value, called intrinsic value, which is Fresenius Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fresenius Medical's market value can be influenced by many factors that don't directly affect Fresenius Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fresenius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fresenius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fresenius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Fresenius Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Fresenius Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Fresenius Medical.
| 10/25/2025 |
| 01/23/2026 |
If you would invest 0.00 in Fresenius Medical on October 25, 2025 and sell it all today you would earn a total of 0.00 from holding Fresenius Medical Care or generate 0.0% return on investment in Fresenius Medical over 90 days. Fresenius Medical is related to or competes with Universal Health, Tenet Healthcare, Encompass Health, DaVita HealthCare, Smith Nephew, Royalty Pharma, and Hologic. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally More
Fresenius Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Fresenius Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Fresenius Medical Care upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.21) | |||
| Maximum Drawdown | 10.14 | |||
| Value At Risk | (3.83) | |||
| Potential Upside | 3.0 |
Fresenius Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fresenius Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Fresenius Medical's standard deviation. In reality, there are many statistical measures that can use Fresenius Medical historical prices to predict the future Fresenius Medical's volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.42) | |||
| Total Risk Alpha | (0.52) | |||
| Treynor Ratio | (0.27) |
Fresenius Medical January 23, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | (0.26) | |||
| Mean Deviation | 1.31 | |||
| Coefficient Of Variation | (603.18) | |||
| Standard Deviation | 1.98 | |||
| Variance | 3.91 | |||
| Information Ratio | (0.21) | |||
| Jensen Alpha | (0.42) | |||
| Total Risk Alpha | (0.52) | |||
| Treynor Ratio | (0.27) | |||
| Maximum Drawdown | 10.14 | |||
| Value At Risk | (3.83) | |||
| Potential Upside | 3.0 | |||
| Skewness | (1.19) | |||
| Kurtosis | 3.95 |
Fresenius Medical Care Backtested Returns
Fresenius Medical Care secures Sharpe Ratio (or Efficiency) of -0.17, which denotes the company had a -0.17 % return per unit of risk over the last 3 months. Fresenius Medical Care exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Fresenius Medical's Standard Deviation of 1.98, mean deviation of 1.31, and Variance of 3.91 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.27, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Fresenius Medical will likely underperform. At this point, Fresenius Medical Care has a negative expected return of -0.33%. Please make sure to confirm Fresenius Medical's total risk alpha, as well as the relationship between the kurtosis and day typical price , to decide if Fresenius Medical Care performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.20 |
Weak predictability
Fresenius Medical Care has weak predictability. Overlapping area represents the amount of predictability between Fresenius Medical time series from 25th of October 2025 to 9th of December 2025 and 9th of December 2025 to 23rd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Fresenius Medical Care price movement. The serial correlation of 0.2 indicates that over 20.0% of current Fresenius Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.2 | |
| Spearman Rank Test | 0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 0.74 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.